MedTrace Logo

Diabetes Companion App for Adults With Diabetes and Their Carers

NCT05535842 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2023-03-27

No results posted yet for this study

Summary

Diabetes self-management support, education, and training are increasingly being delivered through digital technology such as mobile phones. This protocol aims to evaluate the effectiveness of GLOW, a diabetes companion app with a conversational agent.

Conditions

Interventions

OTHER

GLOW

GLOW is an app for type 2 diabetes support and education that uses a conversational agent to help users develop self-management skills and learn about diabetes and healthy behaviours. This is achieved through a range of interactive strategies.

Sponsors & Collaborators

  • Tan Tock Seng Hospital

    collaborator OTHER

  • Ministry of Health, Singapore

    collaborator OTHER_GOV

  • Nanyang Technological University

    lead OTHER

Principal Investigators

  • Daniel Ek Kwang Chew, MD · Tan Tock Seng Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2023-08-31
Completion
2023-09-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05535842 on ClinicalTrials.gov